Cervical cancer still represents a major public health problem, being the fourth most
common cancer in incidence and mortality in women worldwide. These figures are …

Nanomedicines have gained popularity due to their potential therapeutic applications,
especially cancer treatment. Targeted nanoparticles can deliver drugs directly to cancer …

Enhanced aerobic glycolysis constitutes an additional source of energy for tumor
proliferation and metastasis. Human papillomavirus (HPV) infection is the main cause of …

The tumor microenvironment (TME) directly determines patients' outcomes and therapeutic
efficiencies. An in‐depth understanding of the TME is required to improve the prognosis of …

Background: Serpin peptidase inhibitor clade H, member 1 (SERPINH1) is a gene encoding
a member of the serpin superfamily of serine proteinase inhibitors. The upregulated of …

The intratumor heterogeneity of human papillomavirus (HPV)‐related cervical cancer
remains poorly defined. We performed single‐cell RNA sequencing on 18 046 individual …

Although infection with human papillomavirus (HPV) is associated with nearly all cervical
cancers (CC), a small proportion are HPV-negative. Recently, it has become clear that HPV …

Human papillomavirus (HPV)-induced carcinogenesis critically depends on the viral early
protein 7 (E7), making E7 an attractive therapeutic target. Here, we report that the E7 …

Cervical cancer is now the fourth most prevalent malignancy in women worldwide,
representing a tremendous burden of cancer. The heterogeneity of complex tumor …

Prophylactic vaccines against human papillomavirus (HPV) have proven efficacy in those
who have not been infected by the virus. However, they do not benefit patients with …